Syngene Intl gains after Q4 PAT rises 20 per cent to Rs 120 cr
Syngene's consolidated EBITDA jumped 24 per cent to Rs 225 crore in Q4 March 2020 from Rs 181 crore in Q4 March 2019
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Syngene International
Syngene International converts lab into COVID-19 RT-PCR testing centre
A team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory…
Syngene opens R&D centre in Genome Valley, Hyderabad
The centre, located in Genome Valley, is spread across 52000 sq ft with an initial strength of around 150 scientists
Syngene…
Syngene International to appoint Sibaji Biswas as CFO
Biswas brings more than 20 years of extensive experience in finance and related functions
Syngene International announced the…
Dr Mahesh Bhalgat appointed as Chief Operating Officer at Syngene International
Dr Bhalgat is recognised for his contribution to the commercialization of diagnostic kits, biopharmaceuticals and WHO…
Syngene delivers sustained growth in Q4 FY16
Revenue grows 31 per cent to Rs 334 crore; EBITA up by 23 per cent to Rs 106 crore
Syngene appoints Jonathan Hunt as CEO-designate
Hunt will be responsible for strengthening Syngene’s relations with its existing global customers
Syngene International IPO oversubscribed 31 times
The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene
Syngene International's (Syngene) Initial…